Marco Gründl (Marco Jessen)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Transcription Factor

Tyrosine Kinase

Top Venues

Molecular cancer research : MCR

The EMBO journal

This page only lists publications with an associated author ORCID identifier.

Publications

Marco Gründl, Dörthe Gertzmann, Franziska Liss, Franziska Zenk, Laura Bähner, Victoria Schöffler, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Björn von Eyss, Stefan Gaubatz
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Oncogene 43 (8) (2024)
Marco Gründl, Dörthe Gertzmann, Franziska Liss, Franziska Zenk, Laura Bähner, Victoria Schöffler, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Björn von Eyss, Stefan Gaubatz
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Oncogene 43 (8) (2024)
Marco Gründl, Dörthe Gertzmann, Franziska Liss, Franziska Zenk, Laura Bähner, Victoria Schöffler, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Björn von Eyss, Stefan Gaubatz
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Oncogene 43 (8) (2024)
Marco Gründl, Dörthe Gertzmann, Franziska Liss, Franziska Zenk, Laura Bähner, Victoria Schöffler, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Björn von Eyss, Stefan Gaubatz
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Oncogene 43 (8) (2024)
Marco Gründl, Dörthe Gertzmann, Franziska Liss, Franziska Zenk, Laura Bähner, Victoria Schöffler, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Björn von Eyss, Stefan Gaubatz
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Oncogene 43 (8) (2024)
Marco Gründl, Dörthe Gertzmann, Franziska Liss, Franziska Zenk, Laura Bähner, Victoria Schöffler, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Björn von Eyss, Stefan Gaubatz
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Oncogene 43 (8) (2024)
Yuliya Kurlishchuk, Anita Cindric Vranesic, Marco Gründl, Alexandra Kipping, Christin Ritter, KyungMok Kim, Paul Cramer, Björn von Eyss
A non-canonical repressor function of JUN restrains YAP activity and liver cancer growth. The EMBO journal (2024)
Marco Gründl, Dörthe Gertzmann, Franziska Liss, Franziska Zenk, Laura Bähner, Victoria Schöffler, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Björn von Eyss, Stefan Gaubatz
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Oncogene (2024)
Kyung Mok Kim, Anna Mura-Meszaros, Marie Tollot, Murali Shyam Krishnan, Marco Gründl, Laura Neubert, Marco Groth, Alejo E Rodriguez-Fraticelli, Arthur Flohr Svendsen, Stefano Campaner, Nico Andreas, Thomas Kamradt, Steve Hoffmann, Fernando D Camargo, Florian H Heidel, Leonid V Bystrykh, Gerald de Haan, Björn von Eyss
Taz protects hematopoietic stem cells from an aging-dependent decrease in PU.1 activity. Nature communications 13 (1) (2022)
Marina Leone, Salvador Cazorla-Vázquez, Fulvia Ferrazzi, Janica L Wiederstein, Marco Gründl, Grit Weinstock, Silvia Vergarajauregui, Markus Eckstein, Marcus Krüger, Stefan Gaubatz, Felix B Engel
IQGAP3, a YAP Target, Is Required for Proper Cell-Cycle Progression and Genome Stability. Molecular cancer research : MCR 19 (10) (2021)
Marco Gründl, Susanne Walz, Laura Hauf, Melissa Schwab, Kerstin Marcela Werner, Susanne Spahr, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Stefan Gaubatz
Interaction of YAP with the Myb-MuvB (MMB) complex defines a transcriptional program to promote the proliferation of cardiomyocytes. PLoS genetics 16 (5) (2020)